Results 41 to 50 of about 27,301 (241)
DEVELOPMENT AND IN VITRO CHARACTERIZATION OF POLYMER-BASED NASAL FORMULATIONS OF LEVOTHYROXINE
, 2020 BACKGROUND. Hypothyroidism patients, unable to absorb oral levothyroxine rely on expensive and inconvenient intramuscular injections for life-time hormone replacement.
Esomchukwu, Vin-Boris Obinna
core
Equine Veterinary Journal, EarlyView.Abstract Background Treatment with the sodium‐glucose co‐transporter 2 (SGLT2) inhibitor canagliflozin in insulin dysregulated (ID) horses has shown promising results in randomised clinical trials. Larger field studies are needed to further evaluate treatment responses and potential adverse effects under real‐world conditions.
Moa Hällbom +3 more
wiley +1 more source
Bioequivalence studies for levothyroxine [PDF]
The AAPS Journal, 2005 The Food and Drug Administration (FDA) Guidance for Bioavailability and Bioequivalence Studies for Levothyroxine has been challenged by companies that manufacture brand-name products. Their contention is that the current guidance does not adequately address the endogenous background levels of the drug, and that the ratios of the PK parameters, a basis ...
openaire +2 more sources
Fabrication of Levothyroxine Particles Encapsulated with Apatite
, 2017 Apatite nuclei were obtained by raising pH of an acellular simulated body fluid (SBF). The apatite nuclei and levothyroxine particles were dispersed in an ultrapure water and the apatite nuclei were attached to the surface of the levothyroxine particles.
Takeshi Yabutsuka +2 more
core +1 more source
Journal of Parenteral and Enteral Nutrition, EarlyView.Abstract Background This study aimed to assess the incidence and identify risk factors associated with the development of propofol‐induced hypertriglyceridemia in critically ill trauma patients who required nutrition therapy. Methods Adult patients (aged >17 years) admitted to the trauma intensive care unit who received propofol for >24 h and had a ...
Emma S. Lemke +5 more
wiley +1 more source
Choreathetosis due to abuse of levothyroxine
, 2009 Choreathetosis due to thyrotoxicosis is a rare movement disorder of acute onset. Here we present the first report of choreathetosis secondary to abuse of levothyroxine.
Kondziella, Daniel, +2 more
core +1 more source
Functional constipation in children and young adults with Prader–Willi syndrome
JPGN Reports, EarlyView.Abstract Objectives Prader–Willi Syndrome (PWS) is characterized by hyperphagia, endocrinopathies, and gastrointestinal abnormalities. Clinical concerns about constipation and fecal incontinence (FI) are common, but no studies to date have clear data on functional defecation disorders in children with PWS.
Melinda J. Pierce +3 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Microscopic colitis (MC) typically presents with chronic, non‐bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa‐decarboxylase inhibitor (LDDCI) therapy.
Romana Hintner +10 more
wiley +1 more source
Dose levotyroxine consumption in hypothyroid patients before dinner change the levels of TSH and T4?
Caspian Journal of Internal Medicine, 2015 Background: Levothyroxine is commonly used in the treatment of patients with hypothyroidism. Levothyroxine is often administered in the morning, on an empty stomach, to increase its absorption. However, many patients have trouble for taking levothyroxine
Shahram Ala +5 more
doaj
European Thyroid JournalApalutamide, a selective androgen receptor antagonist, is a new treatment for prostate cancer. Among the side effects observed during apalutamide treatment, an increased risk of hypothyroidism has been reported, particularly in patients previously ...
Florie Quattrochi +2 more
doaj +1 more source